GAL and ovarian cancer: The MTT assay showed that SKOV3-gal cells were killed when culturing with both PBMC and serum, implying that anti-Gal antibody in ovarian cancer patients’ serum can bind with SKOV3-gal cells and induce targeting of tumor cells to APCs.